一个目标发现管道确定ILT3作为多发性骨髓瘤免疫治疗的目标
Francesco Di Meo1, Anjushree Iyer2, Keith Akama2
1Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA; Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center, Tampa, FL, USA.
Cell reports. Medicine
|July 19, 2023
概括
研究人员通过分析细胞表面蛋白质,确定了多发性骨髓瘤 (MM) 免疫治疗的有希望的新点. 一种针对ILT3的新型双特异性T细胞吸引剂在临床前模型中显示出显著的抗癌作用,为有效的MM治疗提供了希望.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 蛋白质组学是指蛋白质组学.
背景情况:
- 多发性骨髓瘤 (MM) 是一种致命的血细胞恶性瘤,治疗选择有限.
- 开发有效的免疫疗法需要确定MM细胞的特定点.
研究的目的:
- 识别和验证用于多发性骨髓瘤免疫治疗的新型细胞表面蛋白点.
- 开发和评估一种新型的双特异性T细胞吸引剂,针对已验证的MM抗原.
主要方法:
- 来自MM细胞系和患者样本的质谱和RNA测序数据的综合分析.
- 生物信息过超过4000个候选蛋白质,以识别高度表达的细胞表面标记物.
- 在患者样本和健康细胞中使用流细胞计验证目标表达.
- 在体外和体内对针对ILT3.3的双特异性T细胞参与剂进行了体外和体内评估.
主要成果:
- 六个候选抗原 (ILT3,SEMA4A,CCR1,LRRC8D,FCRL3,IL12RB1) 和BCMA显示出有利的表达特征.
- 一种针对ILT3的两种特异性T细胞激活剂在体外表现出强大的细胞毒性.
- 在体内研究显示,小鼠接受ILT3向性参与剂治疗时,瘤负担降低,生存时间延长.
结论:
- 这项研究确定了MM相关的抗原,有望用于免疫疗法开发.
- 一种新的ILT3向的双特异性T细胞吸引剂显示出对多发性髓瘤的治疗潜力.
相关概念视频
Tumor Immunotherapy
560
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
560
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K


